BioSpace News Archive

Deals

“Organism Company” Ginkgo Bioworks Lands Massive SPAC Deal

Biotechnology firm Ginkgo Bioworks is going public via a merger with Soaring Eagle Acquisition Corp.

May 11, 2021
·
3 min read
·
Mark Terry
Business

Three Companies Land Fresh Funds to Advance Pipelines

2021 is shaping up to be another banner year for biotech companies as they advance the next gen technologies and therapeutics for the health of all. Here’s a few raking in cash for their programs today.

May 11, 2021
·
3 min read
·
Kate Goodwin
FDA

Pfizer/BioNTech COVID-19 Vaccine Wins EUA in Young Teens

The U.S. FDA expanded the Emergency Use Authorization for the Pfizer and BioNTech vaccine to include adolescents ages 12 to 15 after clinical data showed 100% efficacy response.

May 11, 2021
·
3 min read
·
Alex Keown
Drug Development

Cutting-Edge Tech: Highlights from the American Society of Gene & Cell Therapy

The 24th Annual meeting of the American Society of Gene & Cell Therapy presents cutting-edge work in the booming area of gene and cell therapy. Here’s a look at a few of the highlights.

May 11, 2021
·
4 min read
·
Mark Terry
Business

Biogen Pushes Deeper into Gene Therapy with Capsigen Collaboration

Biogen and Capsigen forged a strategic collaboration to engineer novel adeno-associated virus (AAV) capsids that have the potential to become transformative gene therapies that treat underlying genetic causes of various central nervous system and neuromuscular disorders.

May 11, 2021
·
2 min read
·
Alex Keown
Drug Development

FDA Clears Samus Drug for Glioma Phase Ib Study

Clearance of the IND allows Samus to proceed with a Phase Ib trial to assess the safety, tolerability and pharmacokinetics of PU-AD in a small group of patients with recurrent malignant glioma.

May 11, 2021
·
2 min read
·
Brandon May
Bio NC

2021 COVID-19 News: India Variant a Global Concern, Low Risk of Serious Long Term Effects and More

Please check out the biopharma industry’s COVID-19 stories that are trending for May 11, 2021.

May 11, 2021
·
5 min read
·
BioSpace Editorial Staff
Business

Lilly Intensifies RNA-Focused Drug Development with MiNA Therapeutics’ saRNA Platform

Eli Lilly announced a drug development collaboration with MiNA Therapeutics Limited focusing on five novel drug candidates that could be worth up to $245 million.

May 11, 2021
·
2 min read
·
Alex Keown
Deals

Valneva Announces Closing of $107.6 million Global Offering

Valneva’s ordinary shares are listed on Euronext Paris under the symbol “VLA” and its ADSs are listed on the Nasdaq Global Select Market under the symbol “VALN”.

May 11, 2021
·
5 min read
Business

Innate Pharma First Quarter 2021 Report

Lacutamab TELLOMAK trial progresses as KIR3DL2-expressing mycosis fungoides cohort advances to Stage 2 after positive early signal

May 11, 2021
·
7 min read